Advertisement

Diagnosing Type II Diabetes and Choosing Medications in Patients with Obesity

  • Rekha B. KumarEmail author
Chapter

Abstract

A 48-year-old female presents to her primary care doctor for an annual visit. She was told she had the metabolic syndrome at her physical 1 year ago when she had a hemoglobin A1c of 6.1%, hypertension (BP of 145/90), and hypertriglyceridemia (170 mg/dl). At that time, she was told of her risk of developing type II diabetes and advised to lose weight. Over the past year, the patient has gained 12 lbs and attributes her weight gain to stress and inability to prioritize a healthy diet due to balancing her career with taking care of her children. Her diet consists of high-fat and high-carbohydrate foods with fast food in the diet several times per week including processed baked goods and sugar-sweetened beverages with lunch and dinner. She has a desk job and drives back and forth to her office with no additional structured exercise. She has a family history of obesity and type II diabetes in her maternal grandmother but reports that her parents are normal weight. She does not drink alcohol or smoke. She has two children and had diet-controlled gestational diabetes during her second pregnancy.

Keywords

Type II diabetes Metabolic syndrome Glucose intolerance Elevated blood pressure Prediabetes 

References

  1. 1.
    Motillo S, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.CrossRefGoogle Scholar
  2. 2.
    Jensen MD, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985–3023.CrossRefGoogle Scholar
  3. 3.
    American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–27.CrossRefGoogle Scholar
  4. 4.
    Diabetes Prevention Program Research Group. N Engl J Med. 2002;346:393–403. https://www.nejm.org/doi/full/10.1056/NEJMoa012512
  5. 5.
    Garber, et al. Consensus statement by The American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2018 executive summary. Endocr Pract. 2018;24(5):499.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Comprehensive Weight Control Center, Division of EndocrinologyDiabetes and Metabolism, Weill Cornell Medical CollegeNew YorkUSA

Personalised recommendations